Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ AJUBA Polyclonal Antibody
GREENER_CHOICE

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5109373

Catalog No. PIPA5109373


Only null left
Add to Cart

Description

Description

Immunogen sequence: MERLGEKASR LLEKFGRRKG ESSRSGSDGT PGPGKGRLSG LGGPRKSGPR GATGGPGDEP LEPAREQGSL DAERNQRGSF EAPRYEGSFP AGPPPTRALP.

AJUBA (Ajuba LIM Protein) is a Protein Coding gene. Diseases associated with AJUBA include Wilson-Turner X-Linked Mental Retardation Syndrome and Syndromic X-Linked Intellectual Disability. Among its related pathways are Hippo signaling pathway and Adhesion. Gene Ontology (GO) annotations related to this gene include chromatin binding and actin filament binding. An important paralog of this gene is LIMD1.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

AJUBA
Polyclonal
Unconjugated
AJUBA
AJUBA; ajuba homolog; ajuba LIM protein; Ajuba protein; JUB; jub, ajuba homolog; LIM domain-containing protein ajuba; protein ajuba
Rabbit
Affinity Chromatography
RUO
16475, 84962, 85265
-20°C, Avoid Freeze/Thaw Cycles
Liquid
ELISA, Western Blot
0.52 mg/mL
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Q5U2Z2, Q91XC0, Q96IF1
AJUBA
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human Ajuba (NP_1162651).
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.